hyperlipidemia
Search documents
NewAmsterdam Pharma Company (NasdaqGM:NAMS) 2026 Conference Transcript
2026-02-11 14:32
NewAmsterdam Pharma Company (NasdaqGM:NAMS) 2026 Conference February 11, 2026 08:30 AM ET Company ParticipantsIan Somaiya - CFOConference Call ParticipantsDebjit Chattopadhyay - Senior Managing Director and Senior Biotech AnalystDebjit ChattopadhyayAll right, good morning, and thank you for joining Guggenheim's 2026 Emerging Outlook Biotech Summit. I'm Debjit, one of the therapeutic analysts, and my privilege to welcome our first presenting company, NewAmsterdam Pharma. Joining us is Ian Somaiya, company CF ...